Sahin AA, Myhre M, Ro JY, Sneige N, Dekmezian RH, Ayala AG. Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma. Acta Cytol. 1991;35(3):277–80.
CAS
PubMed
Google Scholar
Eble J, Sauter G, Epstein J. Pathology and genetics: tumours of the urinary system and male genital organs. . WHO Classification of Tumours. Lyon: IARC press; 2004.
Google Scholar
Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, Montironi R, Sibonye M, Fritsche HM, Lopez-Beltran A, et al. The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma. Int J Cancer. 2011;129(2):346–54.
Article
CAS
Google Scholar
Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442–54.
Article
CAS
Google Scholar
Thiery JP, Chopin D. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 1999;18(1):31–42.
Article
CAS
Google Scholar
Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, Sancho E, Dedhar S, De Herreros AG, Baulida J. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem. 2002;277(42):39209–16.
Article
CAS
Google Scholar
Boulay JL, Dennefeld C, Alberga A. The Drosophila developmental gene snail encodes a protein with nucleic acid binding fingers. Nature. 1987;330(6146):395–8.
Article
CAS
Google Scholar
Lim MG, Adsay NV, Grignon DJ, Osunkoya AO. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma. Mod Pathol. 2011;24(2):241–7.
Article
CAS
Google Scholar
Mai KT, Park PC, Yazdi HM, Saltel E, Erdogan S, Stinson WA, Cagiannos I, Morash C. Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases. Eur Urol. 2006;50(5):1111–4.
Article
Google Scholar
Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90.
Article
CAS
Google Scholar
Ghoul A, Serova M, Astorgues-Xerri L, Bieche I, Bousquet G, Varna M, Vidaud M, Phillips E, Weill S, Benhadji KA, et al. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells. Cancer Res. 2009;69(10):4260–9.
Article
CAS
Google Scholar
Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, Bussink J. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol. 2011;99(3):344–8.
Article
CAS
Google Scholar
Baranwal S, Alahari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun. 2009;384(1):6–11.
Article
CAS
Google Scholar
Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 1993;53(14):3241–5.
CAS
PubMed
Google Scholar
Syrigos KN, Krausz T, Waxman J, Pandha H, Rowlinson-Busza G, Verne J, Epenetos AA, Pignatelli M. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer. 1995;64(6):367–70.
Article
CAS
Google Scholar
Keck B, Wach S, Kunath F, Bertz S, Taubert H, Lehmann J, Stockle M, Wullich B, Hartmann A. Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder. Ann Surg Oncol. 2013;20(7):2440–5.
Article
Google Scholar
Bruyere F, Namdarian B, Corcoran NM, Pedersen J, Ockrim J, Voelzke BB, Mete U, Costello AJ, Hovens CM. Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers. Urol Oncol. 2010;28(6):591–6.
Article
Google Scholar
Kosaka T, Kikuchi E, Mikami S, Miyajima A, Shirotake S, Ishida M, Okada Y, Oya M. Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion. Clin Cancer Res. 2010;16(23):5814–23.
Article
CAS
Google Scholar
Nomura S, Suzuki Y, Takahashi R, Terasaki M, Kimata R, Hamasaki T, Kimura G, Shimizu A, Kondo Y. Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis. BMC Urol. 2013;13:73.
Article
Google Scholar
Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, Agnantis NJ, Pavlidis N. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer. 2002;38(18):2362–70.
Article
CAS
Google Scholar
Rybak JN, Roesli C, Kaspar M, Villa A, Neri D. The extra-domain a of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res. 2007;67(22):10948–57.
Article
CAS
Google Scholar
Malmstrom PU, Larsson A, Johansson S. Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer. Br J Urol. 1993;72(3):307–10.
Article
CAS
Google Scholar
Menendez V, Fernandez-Suarez A, Galan JA, Perez M, Garcia-Lopez F. Diagnosis of bladder cancer by analysis of urinary fibronectin. Urology. 2005;65(2):284–9.
Article
Google Scholar
Goto K. CD138 expression is observed in the Urothelial epithelium and in various Urothelial carcinomas, and cannot be evidence for Plasmacytoid Urothelial carcinoma. Int J Surg Pathol. 2016;24(7):614–9.
Article
Google Scholar
Li Q, Assel M, Benfante NE, Pietzak EJ, Herr HW, Donat M, Cha EK, Donahue TF, Bochner BH, Dalbagni G. The impact of Plasmacytoid variant histology on the survival of patients with Urothelial carcinoma of bladder after radical cystectomy. Eur Urol Focus. 2019;5(1):104–8.
Article
Google Scholar